Covid-19: Priority for biobank applications in connection with covid-19
Due to the current situation, the Swedish Medical Products Agency and the Swedish Ethical Review Authority will prioritise applications linked to Covid -19 .
Since research on Covid-19 is of great importance to public health, all Healthcare Principals’ biobanks in Sweden, have reached a joint decision that biobank applications related to Covid-19 shall be given priority until further notice. Several biobanks can also offer prioritised sample collecting.
Several inquiries are already being processed around the country and all Biobank Coordinators and Regional Biobank Centres (RBC) will assist in managing the applications to shorten the processing time as much as possible.
The goal is to have applications ready within a week.
To ensure rapid processing of biobank applications, linked to Covid-19, contact the relevant Biobank Coordinator or the Regional Biobank Centre (RBC) as early as possible, preferably at the planning phase of the study. All contacts and support functions can be found here >>